Project will strengthen domestic production of antibody and other protein-based therapies
Mississauga – The Government of Canada continues to strive for innovative solutions and prioritize the revitalization of long-term domestic biomanufacturing capacity, positioning Canada at the forefront of antibody therapeutic development.
Today, Charles Sousa, Parliamentary Secretary to the Minister of Public Services and Procurement, on behalf of François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a contribution of $22.4 million through the Strategic Innovation Fund (SIF) to support a $64.1 million project by Eurofins CDMO Alphora Inc.
This investment will support the construction of a new biologics facility, increasing domestic production capacity for antibodies and protein-based therapeutics that will allow Canadians to better respond to future pandemics. The facility will also enable Eurofins CDMO Alphora Inc. to accelerate clinical testing and the speed at which novel therapeutics are brought to market.
With this contribution, Eurofins CDMO Alphora Inc. will create 120 jobs and 65 co-op positions as well as have the ability to produce materials for clinical trials and meet commercial requirements for a production capacity of up to 24.9 million vials annually.
“Rebuilding a robust life sciences sector remains at the forefront of Canadian economic development. Today’s investment in Eurofins CDMO Alphora Inc. is yet another example of our government’s commitment to secure and strengthen our domestic biomanufacturing and life sciences sector, providing additional safeguards against future pandemics while helping create good jobs for Canadians.” – François-Philippe Champagne, Minister of Innovation, Science and Industry
“This projects reaffirms Canada’s commitment to life sciences and innovation, while growing the local economy. Today we mark an important milestone with the announcement of Eurofins’ new Mississauga facility, which will increase Canada’s domestic production of life‑saving therapeutics for all Canadians.” – Charles Sousa, Parliamentary Secretary to the Minister of Public Services and Procurement